Therapeutic mAbs
Monoclonal antibodies development and applications. These therapeutic mAbs are characterized for binding monoespecifically to certain cells and proteins.
Therapeutic mAbs, Biosimilars
Therapeutic Monoclonal Antibody Characterization: Using Clinical-Grade Reference Drugs to Enhance Early Development
Characterization of therapeutic monoclonal antibodies are important to screen the right mAb molecule by defining the critical quality attributes.
Therapeutic mAbs, Scientific Resources
Therapeutic Antibodies: The Different Formats
The latest antibody engineering toolbox allows exploitation of the modular nature of antibodies to create a remarkable array of diverse and flexible formats of therapeutic antibodies. It is now possible to construct non-natural therapeutic antibodies with predetermined properties on a large scale.
Therapeutic mAbs
Using Antibody Drug Conjugates (ADC) for Therapy
Delivering chemotherapy with the specificity of monoclonal antibodies!
Therapeutic mAbs, Analytics, News
Host Cell Protein Analysis for Biologics Development
What are host cell proteins in biologic drugs?
Therapeutic mAbs, News, Scientific Resources
Therapeutic Antibodies as Immune Checkpoint Inhibitors
Immunotherapy and Immune checkpoint inhibitors
Bispecific antibodies, Therapeutic mAbs
Bispecific Antibodies: The Next Generation of Antibody Therapeutics (Part 2)
Bispecific Antibodies: Therapeutic applications and clinical pipeline. Bispecific antibodies have triggered considerable interest in the medical field and in the pharmaceutical industry over the last few years.
Therapeutic mAbs, Biosimilars
Therapeutic Antibodies to Treat Cancer Targeting CD20
Therapeutic antibodies for cancer targeting CD20 have been successfully used in immunotherapies to treat B-cell malignancies and auto-immune diseases.
Therapeutic mAbs, Biosimilars
Reference Drugs (RMPs/RLDs) and Reference Standards: Exploring the Difference
It is important to first establish a reference standard while assessing biosimilarity between a biosimilar product and the reference product.
